Search Results for: c21

0 126

C21 Investments Announces Transition to U.S. GAAP for Q4

C21 Investments (CSE: CXXI) (OTCQX: CXXIF) (“C21” or the “Company”) a vertically-integrated cannabis company, today…

 Leave a comment    Posted in Uncategorized
0 178

C21 Investments Announces Q2 Results

C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) (“C21” or the “Company”), a vertically integrated cannabis company,…

 Leave a comment    Posted in Uncategorized
2 262

C21 Investments Announces Q1 Results

C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) (“C21” or the “Company”), a vertically integrated cannabis…

 Leave a comment    Posted in Uncategorized
0 275

C21 Investments Announces Year End Results

C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) (“C21” or the “Company”), a vertically integrated cannabis…

 Leave a comment    Posted in MSO News Tagged
0 343

C21 Investments Revises Release Date of Fiscal Year End Financial Results

C21 Investments (CSE: CXXI) (OTCQX: CXXIF) (“C21” or the “Company”) a vertically-integrated cannabis company, today…

 Leave a comment    Posted in MSO News Tagged
0 379

C21 Announces Release Date of Fiscal Year End Financial Results

C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) (“C21” or the “Company”), a vertically-integrated cannabis company today…

 Leave a comment    Posted in MSO News Tagged
0 297

C21 Investments Announces Appointment of CB1 Capitals Todd Harrison to its Board of Directors; Change of Auditor

C21 Investments Inc. (CSE: CXXI) and (OTCQX: CXXIF), a leading vertically integrated cannabis company, today…

 Leave a comment    Posted in Uncategorized Tagged
0 112

Trulieve Celebrates Grand Opening of New Tampa Dispensary – 110th Dispensary In Florida

Florida’s leading medical cannabis company to open its 110th dispensary in the state, invites Tampa community to join…

 Leave a comment    Posted in MSO News
0 84

Cansortium Reports Third Quarter 2021 Financial Results – Revenue up 9% YoY

Q3 Revenue up 9% YoY to $15.6 Million; Adjusted EBITDA up 34% to $4.9 million Management to…

 Leave a comment    Posted in Uncategorized
0 71

Cybin Announces FDA Investigational New Drug and Institutional Review Board Approvals for a Co-Funded Phase 2 Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related Distress

Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics…

 Leave a comment    Posted in Uncategorized